1. Assessment of cardiometabolic risk and prevalence of meeting treatment guidelines among patients with type 2 diabetes stratified according to their use of insulin and/or other diabetic medications: results from INSPIRE ME IAA. Issue 7 (24th February 2013) Authors: Smith, J.; Nazare, J.‐A.; Borel, A.‐L.; Aschner, P.; Barter, P. J.; Van Gaal, L.; Matsuzawa, Y.; Kadowaki, T.; Ross, R.; Brulle‐Wohlhueter, C.; Alméras, N.; Haffner, S. M.; Balkau, B.; Després, J.‐P. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 7(2013:Jul.) Page Start: 629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Do E‐cigarettes induce weight changes and increase cardiometabolic risk? A signal for the future. (29th June 2017) Authors: Verhaegen, A.; Van Gaal, L. Journal: Obesity reviews Issue: Volume 18:Number 10(2017:Oct.) Page Start: 1136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Endothelial protective properties of HDL improve early after roux-en-y gastric bypass but not after diet-induced weight loss: the superior cardiometabolic benefits of RYGB. (September 2016) Authors: Osto, E.; McLoughlin, E.; Doytcheva, P.; Charakida, M.; Van Gaal, L.; Deanfield, J.; Lüscher, T. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed‐ratio combination: a post hoc analysis of the LixiLan‐O and LixiLan‐L trials. Issue 2 (26th November 2019) Authors: Davidson, J. A.; Desouza, C.; Fonseca, V.; Frias, J. P.; Van Gaal, L.; Giorgino, F.; Chao, J.; Dex, T. A.; Roberts, M.; Saremi, A.; Leiter, L. A. Journal: Diabetic medicine Issue: Volume 37:Issue 2(2020) Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MON-PP075: A Unique Definition to Predict Early Stage Cachexia by Ambulatory Cancer Patients. (September 2015) Authors: Meulemans, E.; Wouters, K.; Sels, M.; De Keersmaecker, S.; Verschueren, C.; Bartolomeeussen, L.; De Vroey, V.; De Clerck, L.; Aerts, P.; Vanhoutte, G.; Baert, D.; Vandoninck, C.; Kindt, S.; Schelfhaut, S.; Troch, A.; Ceulemans, L.; Vandenbergh, H.; Rondou, T.; Dewitte, E.; Maes, K. Journal: Clinical nutrition Issue: Volume 34(2015)Supplement 1 Page Start: S155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Relationship of body mass index with efficacy of exenatide twice daily added to insulin glargine in patients with type 2 diabetes. Issue 8 (18th May 2016) Authors: Wolffenbuttel, B. H. R.; Van Gaal, L.; Durán‐Garcia, S.; Han, J. Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 8(2016) Page Start: 829 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH. Issue 10 (25th March 2018) Authors: Boursier, J.; Anty, R.; Vonghia, L.; Moal, V.; Vanwolleghem, T.; Canivet, C. M.; Michalak, S.; Bonnafous, S.; Michielsen, P.; Oberti, F.; Iannelli, A.; Van Gaal, L.; Patouraux, S.; Blanchet, O.; Verrijken, A.; Gual, P.; Rousselet, M.‐C.; Driessen, A.; Hunault, G.; Bertrais, S. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 10(2018) Page Start: 1387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The effect of diet or exercise on ectopic adiposity in children and adolescents with obesity: a systematic review and meta‐analysis. (14th September 2017) Authors: Hens, W.; Vissers, D.; Hansen, D.; Peeters, S.; Gielen, J.; Van Gaal, L.; Taeymans, J. Journal: Obesity reviews Issue: Volume 18:Number 11(2017:Nov.) Page Start: 1310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The U2-spliceosome and its interactors regulate the levels and activity of the LDL receptor in humans. (December 2020) Authors: Zanoni, P.; Panteloglou, G.; Othman, A.; Haas, J.T.; Meier, R.; Rimbert, A.; Futema, M.; Khalil, Y. Abou; Norrelykke, S.F.; Rzepiela, A.J.; Stoma, S.; Stebler, M.; Van Dijk, F.; Wijers, M.; Wolters, J.C.; Dalila, N.; Huijkman, N.; Smit, M.; Gallo, A.; Carreau, V. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗